VS

Vikas Singh

Active Director Director DIN 10204855
DIN 10204855 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Vikas Singh

Data last updated:

Vikas Singh is a Director at Ayupeeth Life Sciences Private Limited (since 2023). The company operates in Paper. Ayupeeth Life Sciences Private Limited reported revenue of ₹42,102 (FY 2025).

DIN 10204855
Primary Designation Director
Industry Paper
First Appointment 03 Jul 2023
Oldest Company Age 3 yrs
Largest company Ayupeeth Life Sciences Private Limited · ₹42,102 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jul 20232023₹42,102 (FY 2025)Active

Directorship timeline

Open interactive timeline →
Ayupeeth Life Sciences Private Limited
Premium access

Shareholding and investment profile for Vikas Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Singh

Vikas Singh currently holds 1 directorship: Ayupeeth Life Sciences Private Limited (Director, since 03 Jul 2023, revenue ₹42,102 (FY 2025)).

Vikas Singh was first appointed on 03 Jul 2023 as Director at Ayupeeth Life Sciences Private Limited.

The current boards of Vikas Singh's companies include Ashish Agarwal (Ayupeeth Life Sciences Private Limited), Shailendra Kumar Naithani (Ayupeeth Life Sciences Private Limited), Shakul Srivastava (Ayupeeth Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available